study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
-
GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
-
Diagnostics | Environmental | EPA | Forestry | Infectious Disease | Non-Profit Research | Oncology | Therapeutics
respiratory infections remain the world’s leading infectious cause of death
On Jan. 6, 2026, a systematic analysis for the Global Burden of Disease Global study shows that lower…
-
Researchers Map Cellular Landscape of the Developing Human Lung
On Aug. 13, 2025, a research team led by investigators at the Translational Genomics Research Institute (TGen), part…
-
Sanofi to acquire Vicebio for $1.15 Billion, expanding respiratory vaccines pipeline
On Jul. 22, 2025, Sanofi announces it has entered into an agreement to acquire Vicebio, a privately held…
-
CDC recommended RSV vaccine for older adults
On Jun. 29, 2023, the Centers for Disease Control and Prevention (CDC) endorsed the CDC Advisory Committee on…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
-
3M and White House announced plan to import 166.5 million additional respirators into the U.S. over the next three months
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
-
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor Co. announced that they had entered into a partnership in…
